OUTCOME OF CHILDREN WITH BRAIN-STEM GLIOMAS AFTER TREATMENT WITH 7800-CGY OF HYPERFRACTIONATED RADIOTHERAPY - A CHILDRENS-CANCER-GROUP PHASE-I II TRIAL/

Citation
Rj. Packer et al., OUTCOME OF CHILDREN WITH BRAIN-STEM GLIOMAS AFTER TREATMENT WITH 7800-CGY OF HYPERFRACTIONATED RADIOTHERAPY - A CHILDRENS-CANCER-GROUP PHASE-I II TRIAL/, Cancer, 74(6), 1994, pp. 1827-1834
Citations number
15
Categorie Soggetti
Oncology
Journal title
CancerACNP
ISSN journal
0008543X
Volume
74
Issue
6
Year of publication
1994
Pages
1827 - 1834
Database
ISI
SICI code
0008-543X(1994)74:6<1827:OOCWBG>2.0.ZU;2-D
Abstract
Background. Brain stem gliomas remain the childhood brain tumors most resistant to treatment. Treatments with hyperfractionated radiotherapy at doses as high as 7560 cGy have been fairly well tolerated. This st udy was undertaken to determine the toxicity and possible efficacy of hyperfractionated radiotherapy in children with brain stem gliomas usi ng 100 cGy of radiation twice daily, to a total dose of 7800 cGy. Meth ods. Sixty-six children (mean age at diagnosis, 7.5 years) with diffus e intrinsic brain stem gliomas were treated. Patients were evaluated f or potential toxicity of treatment, progression-free survival, surviva l, and response to treatment. Results. Objective response to treatment was documented in 20 of 58 (34%) evaluable patients, with 8 (14%) pat ients having a greater than 50% reduction in tumor size. Overall survi val was 35% plus or minus 6% at 1 year and 11% plus or minus 6% at 3 y ears. Intralesional cystic/necrotic radiographic changes developed in nine patients 6 weeks after radiation, and three of these patients sub sequently improved without antitumor intervention. Six of 14 autopsied patients had evidence of probable radiation-induced intralesional nec rotic damage, and in 1, necrosis may have played a role in death. Thir ty-three of 66 patients were treated with steroids for prolonged perio ds. Conclusions. The results of this treatment regimen demonstrate tha t hyperfractionated radiotherapy, as delivered in this study to a tota l dose of 7800 cGy, is relatively well tolerated, but may result in pr olonged steroid-use dependency and possible radiation-associated damag e. Objective responses to treatment were seen in 34% of patients, but these results were not better than those seen at lower doses of hyperf ractionated radiotherapy. There is no evidence that radiation to 7800 cGy results in improved survival for patients with diffuse intrinsic b rain stem gliomas.